MX2018011162A - Metodos de purificacion de colageno 7. - Google Patents

Metodos de purificacion de colageno 7.

Info

Publication number
MX2018011162A
MX2018011162A MX2018011162A MX2018011162A MX2018011162A MX 2018011162 A MX2018011162 A MX 2018011162A MX 2018011162 A MX2018011162 A MX 2018011162A MX 2018011162 A MX2018011162 A MX 2018011162A MX 2018011162 A MX2018011162 A MX 2018011162A
Authority
MX
Mexico
Prior art keywords
methods
recombinant collagen
purifying collagen
purifying
collagen
Prior art date
Application number
MX2018011162A
Other languages
English (en)
Spanish (es)
Inventor
Nichols David
Yang Ting
Quiñones Garcia Igor
Simeone Benjamin
Lillie Raymond
Original Assignee
Phoenix Tissue Repair Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phoenix Tissue Repair Inc filed Critical Phoenix Tissue Repair Inc
Publication of MX2018011162A publication Critical patent/MX2018011162A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Water Supply & Treatment (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MX2018011162A 2016-03-16 2017-03-10 Metodos de purificacion de colageno 7. MX2018011162A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662309030P 2016-03-16 2016-03-16
PCT/US2017/021815 WO2017160636A1 (en) 2016-03-16 2017-03-10 Methods of purifying collagen 7

Publications (1)

Publication Number Publication Date
MX2018011162A true MX2018011162A (es) 2018-11-22

Family

ID=59852081

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018011162A MX2018011162A (es) 2016-03-16 2017-03-10 Metodos de purificacion de colageno 7.

Country Status (7)

Country Link
US (1) US10669327B2 (cg-RX-API-DMAC7.html)
EP (1) EP3429615A4 (cg-RX-API-DMAC7.html)
JP (2) JP6985282B2 (cg-RX-API-DMAC7.html)
CN (1) CN109069592B (cg-RX-API-DMAC7.html)
CA (1) CA3015685A1 (cg-RX-API-DMAC7.html)
MX (1) MX2018011162A (cg-RX-API-DMAC7.html)
WO (1) WO2017160636A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3394095B1 (en) * 2015-12-23 2023-09-27 Phoenix Tissue Repair Inc. Collagen 7 compositions and methods of using the same
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
US10792618B2 (en) * 2018-06-19 2020-10-06 Sartorius Stedim Biotech Gmbh Particle separation and/or purification of a fluid
GB2597416A (en) 2019-04-12 2022-01-26 Geltor Inc Recombinant elastin and production thereof
EP4061446A4 (en) 2019-11-20 2023-11-29 NxStage Medical, Inc. METHODS, DEVICES AND SYSTEMS FOR PROVIDING PERITONEAL DIALYSIS LIQUID FROM A POWDERED CONCENTRATE
CN113121638B (zh) * 2020-01-15 2022-06-14 鲁南制药集团股份有限公司 一种纯化重组蛋白的方法
EP4093761A4 (en) 2020-01-24 2024-04-17 Geltor, Inc. Animal-free dietary collagen
US11504716B2 (en) * 2020-06-05 2022-11-22 Pall Corporation Multiwell device and method of use
CN116547382A (zh) * 2020-10-08 2023-08-04 杰拉泰克公司 从动物细胞系和/或组织外植体生产、分离和/或提取胶原蛋白和/或明胶
KR20240004264A (ko) * 2021-03-04 2024-01-11 젤라텍, 인크. 배양된 동물 세포로부터의 콜라겐을 사용한 재료의 제조 방법
CN114805548B (zh) * 2021-12-29 2023-11-14 江苏创健医疗科技股份有限公司 一种重组胶原蛋白冻干纤维及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO599897A0 (en) * 1997-04-03 1997-05-01 Vidal, Linus Clear collagen for facial implants
ES2704040T3 (es) 2005-09-15 2019-03-13 Wyeth Llc Floculación de proteínas mediante el uso de sales
WO2012149136A1 (en) * 2011-04-26 2012-11-01 The Board Of Trustees Of The Leland Stanford Junior University Production and delivery of a stable collagen
CN103842517A (zh) 2011-08-03 2014-06-04 莲花组织修复公司 胶原蛋白7及相关方法
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9150645B2 (en) * 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
WO2014015314A1 (en) * 2012-07-19 2014-01-23 University Of Southern California Recombinant c7 and methods of use
WO2014110246A1 (en) 2013-01-09 2014-07-17 Shire Human Genetic Therapies, Inc. Methods for purification of arylsulfatase a
JP6694381B2 (ja) 2013-09-24 2020-05-13 エラスタジェン・プロプライエタリー・リミテッドElastagen Pty Ltd タンパク質抽出方法

Also Published As

Publication number Publication date
WO2017160636A1 (en) 2017-09-21
JP2022016605A (ja) 2022-01-21
US20190077845A1 (en) 2019-03-14
CN109069592B (zh) 2023-03-07
JP7340583B2 (ja) 2023-09-07
EP3429615A4 (en) 2019-11-06
EP3429615A1 (en) 2019-01-23
CA3015685A1 (en) 2017-09-21
US10669327B2 (en) 2020-06-02
JP6985282B2 (ja) 2021-12-22
JP2019511498A (ja) 2019-04-25
CN109069592A (zh) 2018-12-21

Similar Documents

Publication Publication Date Title
PH12020500500A1 (en) Pyrazolopyrimidinone compounds and uses thereof
EP4620521A3 (en) Methods and compositions relating to chondrisomes from cultured cells
ZA202211622B (en) Method for selection of high m6p recombinant proteins
MX389228B (es) Composiciones para tratar el cabello.
MX2020014031A (es) Proteinas heterodimericas y usos de las mismas.
MX2021001186A (es) Purinonas como inhibidores de proteasa especifica de ubiquitina 1.
EP4516319A3 (en) Subcutaneous formulations of anti-cd38 antibodies and their uses
MX2024001617A (es) Composiciones biofarmaceuticas.
SG10201811454WA (en) Materials and methods for controlling infections
MX2015011898A (es) Compuestos de pirazolo y usos de los mismos.
SG10201902872YA (en) Ex vivo proliferation of epithelial cells
MY193650A (en) Extracellular matrix compositions
MX2017001971A (es) Composiciones antimetanogenicas y sus usos.
MY190647A (en) Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof
PH12019502036A1 (en) Peptides and methods for the treatment of diabetes
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
WO2016176620A8 (en) Extracellular matrix compositions for the treatment of cancer or immunological diseases
EA201990998A1 (ru) Фармацевтические составы и способы их получения
WO2017093810A3 (en) Composition for intraoral delivery of biologically active peptides and proteins
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
SG10201805890QA (en) Compositions and methods for treatment of abnormal cell growth
AU2015267160A8 (en) Methods and compositions for preventing ischemia reperfusion injury in organs
MY193996A (en) Tripeptide compound, preparation method therefor, and application thereof
WO2018119312A8 (en) Methods and formulations for reducing reconstitution time of lyophilized polypeptides
MX2016002930A (es) Moduladores del receptor x hepatico (lxr).